Status:
COMPLETED
Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Acute Coronary Syndrome
Fear
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary goal of this project is to identify, measure, and influence fear of cardiac event recurrence, a candidate mechanism of change in medication adherence in patients with suspected acute coron...
Detailed Description
Acute coronary syndrome (ACS; myocardial infarction or unstable angina) is a leading cause of morbidity and mortality in the U.S., with \>1 million cases per year. Survivors are at high risk for recur...
Eligibility Criteria
Inclusion
- Age 18 years or older;
- Fluent in English or Spanish;
- A diagnosis of NSTEMI or unstable angina (UA) according to American College of Cardiology criteria;
- Currently enrolled in the protocol titled "Testing biopsychosocial mechanisms of the posthospital syndrome \[PHS\] model of early rehospitalization in cardiac patients" (IRB-AAAR7350 at CUIMC)
- Previously indicated "YES" to the following question in the consent form for the separate protocol (IRB-AAAR7350) in which they are enrolled and willing to be contacted about other future research projects.
- Elevated Threat Perception score in emergency department flagged by automatic scoring (i.e., ≥ 10, the median for 1,000 ACS patients in a separate sample)
- Currently on a daily aspirin regimen prescribed by a doctor OR currently on a daily beta-blocker or statin regimen prescribed by a doctor
- Some comfort using technology such as electronic tablets or smartphones
Exclusion
- Deemed unable to comply with the protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks). This includes patients with a level of cognitive impairment indicative of dementia and patients with current alcohol or substance abuse;
- Deemed to need immediate psychiatric intervention (that is, has to be hospitalized or have some other psychiatric intervention within 72 hours);
- Unavailable for follow-up. This includes patients with a terminal noncardiovascular illness (life expectancy less than 1 year by physician report) and those who indicate they are about to leave the United States;
- Underwent a surgical procedure within the past 24 hours and/or is scheduled for a surgical procedure within the next 24 hours.
Key Trial Info
Start Date :
March 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03853213
Start Date
March 28 2019
End Date
July 31 2020
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NewYork-Presbyterian/Columbia University Irving Medical Center
New York, New York, United States, 10032